Christine Bowman

TL;DR: In this high incidence population, daily tenofovir–emtricitabine conferred even higher protection against HIV than in placebo-controlled trials, refuting concerns that effectiveness would be less in a real-world setting.

TL;DR: The PROUD study population are at substantially higher risk of acquiring HIV infection sexually than the overall population of GMSM attending sexual health clinics in England, and demonstrate that, despite broad eligibility criteria, the population interested in PrEP was highly selective.

TL;DR: A review of the literature details current understanding of the role of HIV specialist nurses and the contribution that they make to HIV care, with limited evidence to indicate clinical effectiveness.

TL;DR: Failure to suppress asymptomatic shedding during prophylactic acyclovir therapy may have implications for sexual transmission to partners and vertical transmission to neonates and requires further study.

TL;DR: HIV-v is safe and can elicit T- and B-cell responses in ART-naive HIV patients that significantly reduce viral load, and appears to have potential as an immunotherapeutic anti-viral agent.